Atreus gets $6M for development of medical imaging technology

03/4/2010 | Ottawa Citizen (Ontario)

Atreus Pharmaceuticals will receive $6 million from French nuclear medicine firm Advanced Accelerator Applications for the development of a medical imaging technology involving a human plasma protein called Annexin V. The technology has the potential to detect conditions, including Alzheimer's disease, at their early stage, the company said.

View Full Article in:

Ottawa Citizen (Ontario)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX